Key result
IL-1β rs1143627 CT+TT genotype linked to ~135% greater risk of major depressive disorder versus CC.
Why the study?
Altered cytokine levels are implicated in major depressive disorder (MDD), and IL-1β rs16944 and rs1143627 polymorphisms may increase depression risk, but their correlation with MDD susceptibility in Bangladesh required evaluation.
Case-Control (n=170)
No
IL-1β rs16944 and rs1143627 polymorphisms are significantly associated with an increased risk of major depressive disorder in the Bangladeshi population.
Answers are grounded in this paper and cite their sources.
IL-1β rs1143627 variant was associated with MDD risk; leaves open causality, generalizability, and need for replication.
BACKGROUND: Epidemiological research suggests that altered levels of cytokine are associated with pathophysiology and the development of major depressive disorder (MDD). Based on earlier study, IL-1β rs16944 and rs1143627 polymorphisms may increase the risk of depression. Here, we aimed to evaluate the correlation between these polymorphisms and MDD susceptibility among the population in Bangladesh. METHODS: Blood samples were collected from 100 MDD patients and 70 matched controls. Study participants were evaluated by DSM-5 criteria and PCR-RFLP method were applied for genotyping. RESULTS: The IL1β rs1143627 and rs16944 polymorphisms were found to have a significant association with the risk of MDD. In case of rs1143627 CT heterozygous genotype (OR = 2.22, 95% CI = 1.08-4.55, p-value = 0.029) and combined CT+TT (OR = 2.35, 95% CI = 1.15-4.79, p-value = 0.019) genotype was strongly associated with the increased risk of MDD in comparison to CC common genotype. Moreover, the over-dominant model indicated a 2.15-fold higher risk for MDD development (OR = 2.15, 95% CI = 1.05-4.40, p-value = 0.036). On the other hand, the IL1β rs16944 polymorphisms revealed that the TC+CC combined genotype in the dominant model showed a 2.06-fold increased risk for MDD development compared to the TT common homozygote (OR = 2.06, 95% CI = 1.06-3.99, p-value = 0.032). CONCLUSION: Studies suggests that IL1β rs16944 and rs1143627 polymorphisms are associated with an increased risk of MDD. These findings will provide us with valuable insights into the pathophysiology of MDD.
No takes yet. Share an insight, caveat, or question.
Toma et al. (2025) conducted a case-control in Major depressive disorder (n=170). IL-1β rs1143627 and rs16944 polymorphisms vs. Healthy controls was evaluated on Risk of major depressive disorder (rs1143627 dominant model CT+TT vs CC) (OR 2.35, 95% CI 1.15-4.79, p=0.019). The IL-1β rs1143627 CT+TT combined genotype was significantly associated with a 2.35-fold increased risk of major depressive disorder compared to the CC common genotype.
Synapse has enriched 10 related papers. Consider them for comparative context: